Is the CSL share price a buy above $300?

Is the CSL Limited (ASX:CSL) share price a buy above $300? It hasn't fallen much since the start of the share market declines.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Is the CSL Limited (ASX: CSL) share price a buy above $300? CSL hasn't actually fallen much since the start of the share market declines.

CSL is the ASX's biggest company, it's a healthcare giant with a market capitalisation well north of $100 billion. For a long time that type of company size was solely the arena for ASX banks and resource shares.

But steady long-term growth has seen the healthcare share come out on top.

How is CSL and the share price going during the coronavirus?

Since 19 February 2020 the CSL share price is down just over 10%. It's one of the few businesses in the ASX 20 to reaffirm its profit guidance for FY20. As a reminder, that profit guidance is between US$2.11 billion to US$2.17 billion at constant currency.

Despite the ongoing issues, the company is still expecting to be able to grow profit. It's a very solid business with long-term growth thanks to its consistent research and development.

CSL said that it has an estimated $1.1 billion of available liquidity. When you combine that liquidity with the fact that it's still making a solid profit, it's clear the business will do just fine. Which should mean the CSL share price continues to perform defensively. 

However, that's not to say there won't be potential issues in FY21. Plasma collections present a challenge, though the company is doing various initiatives to try to mitigate the impact. In the US some states are lifting their restrictions, which could be good news for CSL.

The company said that there are going to be modest delays with its capital projects and clinical trials, but there is potential to accelerate its activity after the crisis has passed to ensure that there's no material change to the original plan.

Foolish takeaway

I don't think that the coronavirus is going to completely derail CSL's growth plans. Its products and services are invaluable for the wider community. I think we need to look ahead to FY22 before there's a normal year of earnings. At this share price, CSL is trading at 33x FY22's estimated earnings.

I believe there are better share investment ideas out there for better value. CSL's size may hamper investor returns.

Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

Here are the top five ASX 200 shares in Macquarie's model growth portfolio

These ASX 200 shares are highly rated by analysts at Macquarie.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Growth Shares

3 ASX shares to buy in 2024 and hold for the next 10 years

Analysts think these top shares are in the buy zone right now.

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Growth Shares

4 ASX growth shares I think will benefit from interest rate cuts in 2024

Not only will home loan holders rejoice, investors of these stocks could also be yelling with joy when the Reserve…

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Growth Shares

3 of the best ASX growth shares to buy now

Analysts see plenty of upside for these buy-rated shares.

Read more »

A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
Growth Shares

Here's why analysts love these buy-rated ASX 200 growth shares

There's a reason analysts are feeling bullish about these companies.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

Big returns could be coming for high-flying Lovisa shares

Morgans doesn't believe it is too late to snap up this hot stock.

Read more »

Smiling young parents with their daughter dream of success.
Growth Shares

Why these ASX 200 growth shares could be top buys now

Analysts are feeling bullish about these growth stocks. Let’s see what they’re saying.

Read more »

Concept image of a man in a suit with his chest on fire.
Growth Shares

Ignore the noise and buy this hot ASX growth stock

A recent pullback may have created a buying opportunity according to Bell Potter.

Read more »